Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Voon Ong

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
European Journal of Rheumatology|August 4, 2018
Severe gangrene in a patient with anti-RNP positive limited cutaneous systemic sclerosis/rheumatoid arthritis overlap syndrome caused by vasculopathy and vasculitisCharles Raine, Benjamin Canning, Jonathan Marks, et al.
Journal of Scleroderma and Related Disorders|June 8, 2023
Relapsing polychondritis in systemic sclerosis: A rare vasculitic mimicCarolina Teles, Chiranthi Kongala Liyanage, Geoffrey Chow, et al.
BMJ Case Reports|January 6, 2019
Autoimmunity and immunodeficiency at the crossroad: autoimmune disorders as the presenting feature of selective IgM deficiencyCorrado Campochiaro, Sirin Atay, Kristina E N Clark, et al.
Pharmacotherapy|June 6, 2024
Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjectsShawn Flanagan, Voon Ong, Thomas Marbury, et al.
Clinical and Experimental Rheumatology|October 18, 2016
UK Scleroderma Study Group (UKSSG) guidelines on the diagnosis and management of scleroderma renal crisisBernadette M Lynch, Edward P Stern, Voon Ong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 2025
Absorption, distribution, metabolism, and excretion of an antiviral drug-Fc conjugate CD388 following subcutaneous administration of <sup>14</sup>C-CD388 in the ratAline Laenen, Shawn Flanagan, Grayson Hough, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 31, 2014
Absorption, distribution, metabolism, and excretion of the novel antibacterial prodrug tedizolid phosphateVoon Ong, Shawn Flanagan, Edward Fang, et al.
Antimicrobial Agents and Chemotherapy|September 14, 2016
Preclinical Evaluation of the Stability, Safety, and Efficacy of CD101, a Novel EchinocandinVoon Ong, Grayson Hough, Michael Schlosser, et al.
The Journal of Antimicrobial Chemotherapy|November 14, 2024
The distinctive pharmacokinetic profile of rezafungin, a long-acting echinocandin developed in the era of modern pharmacometricsDavid Andes, Roger J Brüggemann, Shawn Flanagan, et al.
Cellular Microbiology|June 30, 2016
CD101: a novel long-acting echinocandinYanan Zhao, Winder B Perez, Cristina Jiménez-Ortigosa, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
European Journal of Rheumatology|August 4, 2018
Severe gangrene in a patient with anti-RNP positive limited cutaneous systemic sclerosis/rheumatoid arthritis overlap syndrome caused by vasculopathy and vasculitisCharles Raine, Benjamin Canning, Jonathan Marks, et al.
Journal of Scleroderma and Related Disorders|June 8, 2023
Relapsing polychondritis in systemic sclerosis: A rare vasculitic mimicCarolina Teles, Chiranthi Kongala Liyanage, Geoffrey Chow, et al.
BMJ Case Reports|January 6, 2019
Autoimmunity and immunodeficiency at the crossroad: autoimmune disorders as the presenting feature of selective IgM deficiencyCorrado Campochiaro, Sirin Atay, Kristina E N Clark, et al.
Pharmacotherapy|June 6, 2024
Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjectsShawn Flanagan, Voon Ong, Thomas Marbury, et al.
Clinical and Experimental Rheumatology|October 18, 2016
UK Scleroderma Study Group (UKSSG) guidelines on the diagnosis and management of scleroderma renal crisisBernadette M Lynch, Edward P Stern, Voon Ong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 2025
Absorption, distribution, metabolism, and excretion of an antiviral drug-Fc conjugate CD388 following subcutaneous administration of <sup>14</sup>C-CD388 in the ratAline Laenen, Shawn Flanagan, Grayson Hough, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 31, 2014
Absorption, distribution, metabolism, and excretion of the novel antibacterial prodrug tedizolid phosphateVoon Ong, Shawn Flanagan, Edward Fang, et al.
Antimicrobial Agents and Chemotherapy|September 14, 2016
Preclinical Evaluation of the Stability, Safety, and Efficacy of CD101, a Novel EchinocandinVoon Ong, Grayson Hough, Michael Schlosser, et al.
The Journal of Antimicrobial Chemotherapy|November 14, 2024
The distinctive pharmacokinetic profile of rezafungin, a long-acting echinocandin developed in the era of modern pharmacometricsDavid Andes, Roger J Brüggemann, Shawn Flanagan, et al.
Cellular Microbiology|June 30, 2016
CD101: a novel long-acting echinocandinYanan Zhao, Winder B Perez, Cristina Jiménez-Ortigosa, et al.
Pageof 5